Clinical Trial Update: Pancreatic Islet Mass in Pregnancy in Type 1 Diabetes

View source ↗

Summary

A University of Alberta–led clinical trial evaluating pancreatic islet mass in pregnancy for individuals with Type 1 Diabetes was terminated (NCT00548522).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes, Pregnancy | Status: TERMINATED